Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: David F. Eierman, Ph.D., University of North Carolina at Chapel Hill: The Division of Research Investigations (DRI) of the Office of Research Integrity (ORI) reviewed an investigation conducted by the University of North Carolina at Chapel Hill into possible scientific misconduct on the part of Dr. Eierman while a research assistant at the University of North Carolina. Based in part on Dr. Eierman\'s admission, the University concluded that he committed scientific misconduct by falsifying or fabricating data in biomedical research supported by two Public Health Service grants. The ORI accepted the University\'s conclusions and found that Dr. Eierman engaged in scientific misconduct. Dr. Eierman has fully cooperated with the University of North Carolina and ORI in this matter and has signed a Voluntary Exclusion Agreement under which he has agreed to be excluded from support under Federal grants, contracts, and cooperative agreements for a three-year period beginning December 12, 1994, and ending December 11, 1997, and from service on PHS advisory committees, boards, or peer review groups for the same period. ORI notes that Dr. Eierman\'s cooperation in resolving this matter indicates that he has accepted responsibility for his actions, and this is regarded as a positive factor that was taken into consideration in negotiating the Voluntary Exclusion Agreement. The fabricated and falsified data were reported in two manuscripts that were never published and in Figure 3 of \`\`β\<INF\>1 and β\<INF\>2 Integrin Subunit Regulation of the Monocyte Inflammatory Response,\'\' Cellular and Cytokine Networks in Tissue Immunity (M. Meltzer, and A. Mantovani, Eds.). (1991). New York: Wiley- Liss.
